Prescription drug · NDA AUTHORIZED GENERIC
Clonidine Transdermal System USP, 0.3 mg/day (Clonidine transdermal system) NDC 52817-507
Clonidine .3 mg/d · Patch · Transdermal · TruPharma, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 52817-507-04 | 5281705070452817050704 | 4 POUCH in 1 CARTON (52817-507-04) / 1 PATCH in 1 POUCH / 1 d in 1 PATCHMarketed from Mar 30, 2026 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Clonidine Transdermal System USP, 0.3 mg/day
- Generic name (nonproprietary)
- clonidine transdermal system
- Active ingredients
- Clonidine — .3 mg/d
- Dosage form
- Patch
- Route
- Transdermal
- Labeler
- TruPharma, LLCNDC labeler code 52817
- Product type
- Prescription drug
- Marketing category
- NDA authorized genericApplication NDA 018891
- Marketing start
- Listing expires
- Other FDA classes
- Adrenergic alpha2-Agonists (Mechanism)
- Identifiers
- Product ID 52817-507_cb042bcb-7841-43e9-bf1a-0ab908860766SPL ID cb042bcb-7841-43e9-bf1a-0ab908860766SPL set ID 0fcfcdb5-0662-41d9-919b-c66d4f4f0c8bRxCUI 998671, 998675, 998679UNII MN3L5RMN02
- Pharmacologic class
- Central alpha-2 Adrenergic Agonist
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Transdermal products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N452817050704followed by a unit qualifier and the quantityPackage 52817-0507-04. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Clonidine Transdermal System, USP is indicated in the treatment of hypertension. It may be employed alone or concomitantly with other antihypertensive agents.
Excerpt only. Read the full label for complete information.
About NDC 52817-507
- What is NDC 52817-507?
- 52817-507 is the product NDC for Clonidine Transdermal System USP, 0.3 mg/day, Clonidine .3 mg/d patch, listed with the FDA by TruPharma, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Clonidine Transdermal System USP, 0.3 mg/day (Clonidine transdermal system).
- What is the active ingredient?
- Clonidine.
- Who is the labeler?
- TruPharma, LLC, NDC labeler code 52817. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Clonidine Transdermal System USP, 0.3 mg/day?
- 1 other product NDC are listed under this name. See all Clonidine Transdermal System USP, 0.3 mg/day NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Clonidine Transdermal System USP, 0.3 mg/day products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Clonidine Transdermal System USP, 0.3 mg/dayclonidine transdermal system | Clonidine .3 mg/d | PatchTransdermal | TruPharma, LLC | 52817-612 | 52817-0612-04 |
Other NDCs under NDA 018891
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Catapres-TTS-1clonidine transdermal system | Clonidine .1 mg/d | PatchTransdermal | Technomed Inc. | 82089-101 |
| Catapres-TTS-1clonidine transdermal system | Clonidine .1 mg/d | PatchTransdermal | Technomed Inc. | 82089-201 |
| Catapres-TTS-2clonidine transdermal system | Clonidine .2 mg/d | PatchTransdermal | Technomed Inc. | 82089-102 |
| Catapres-TTS-2clonidine transdermal system | Clonidine .2 mg/d | PatchTransdermal | Technomed Inc. | 82089-202 |
| Catapres-TTS-3clonidine transdermal system | Clonidine .3 mg/d | PatchTransdermal | Technomed Inc. | 82089-103 |
| Catapres-TTS-3clonidine transdermal system | Clonidine .3 mg/d | PatchTransdermal | Technomed Inc. | 82089-203 |
| Clonidine Transdermal System USP, 0.1 mg/dayclonidine transdermal system | Clonidine .1 mg/d | PatchTransdermal | TruPharma, LLC | 52817-505 |
| Clonidine Transdermal System USP, 0.1 mg/dayclonidine transdermal system | Clonidine .1 mg/d | PatchTransdermal | TruPharma, LLC | 52817-610 |
| Clonidine Transdermal System USP, 0.2 mg/dayclonidine transdermal system | Clonidine .2 mg/d | PatchTransdermal | TruPharma, LLC | 52817-506 |
| Clonidine Transdermal System USP, 0.2 mg/dayclonidine transdermal system | Clonidine .2 mg/d | PatchTransdermal | TruPharma, LLC | 52817-611 |
| Clonidine Transdermal System USP, 0.3 mg/dayclonidine transdermal system | Clonidine .3 mg/d | PatchTransdermal | TruPharma, LLC | 52817-612 |